Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPSN - CA2943752097 - Common Stock

5.04 USD
+0.36 (+7.69%)
Last: 12/3/2025, 8:22:28 PM
5.04 USD
0 (0%)
After Hours: 12/3/2025, 8:22:28 PM
Fundamental Rating

6

Taking everything into account, EPSN scores 6 out of 10 in our fundamental rating. EPSN was compared to 209 industry peers in the Oil, Gas & Consumable Fuels industry. While EPSN has a great health rating, its profitability is only average at the moment. EPSN is valued quite cheap, but it does not seem to be growing. This makes EPSN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year EPSN was profitable.
In the past year EPSN had a positive cash flow from operations.
In the past 5 years EPSN has always been profitable.
Each year in the past 5 years EPSN had a positive operating cash flow.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.66%, EPSN is in the better half of the industry, outperforming 65.07% of the companies in the same industry.
Looking at the Return On Equity, with a value of 5.87%, EPSN is in line with its industry, outperforming 46.41% of the companies in the same industry.
EPSN has a better Return On Invested Capital (7.03%) than 62.20% of its industry peers.
EPSN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly below the industry average of 21.47%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

EPSN has a Profit Margin of 12.86%. This is in the better half of the industry: EPSN outperforms 63.16% of its industry peers.
In the last couple of years the Profit Margin of EPSN has declined.
EPSN's Operating Margin of 29.19% is fine compared to the rest of the industry. EPSN outperforms 71.29% of its industry peers.
In the last couple of years the Operating Margin of EPSN has declined.
EPSN has a better Gross Margin (74.48%) than 86.12% of its industry peers.
In the last couple of years the Gross Margin of EPSN has remained more or less at the same level.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EPSN is still creating some value.
Compared to 1 year ago, EPSN has less shares outstanding
Compared to 5 years ago, EPSN has less shares outstanding
There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.18 indicates that EPSN is not in any danger for bankruptcy at the moment.
The Altman-Z score of EPSN (3.18) is better than 83.73% of its industry peers.
EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.18
ROIC/WACC0.81
WACC8.73%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

EPSN has a Current Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
EPSN's Current ratio of 1.93 is fine compared to the rest of the industry. EPSN outperforms 76.56% of its industry peers.
A Quick Ratio of 1.93 indicates that EPSN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.93, EPSN is doing good in the industry, outperforming 78.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.00% over the past year.
EPSN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.77% yearly.
Looking at the last year, EPSN shows a very strong growth in Revenue. The Revenue has grown by 46.76%.
Measured over the past years, EPSN shows a small growth in Revenue. The Revenue has been growing by 3.38% on average per year.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.29 indicates a reasonable valuation of EPSN.
Based on the Price/Earnings ratio, EPSN is valued a bit cheaper than the industry average as 79.90% of the companies are valued more expensively.
EPSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.37.
A Price/Forward Earnings ratio of 10.29 indicates a reasonable valuation of EPSN.
Based on the Price/Forward Earnings ratio, EPSN is valued a bit cheaper than the industry average as 75.12% of the companies are valued more expensively.
EPSN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.20.
Industry RankSector Rank
PE 10.29
Fwd PE 10.29
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EPSN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. EPSN is cheaper than 81.82% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EPSN indicates a somewhat cheap valuation: EPSN is cheaper than 70.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.33
EV/EBITDA 4.28
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EPSN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.25%, EPSN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.93, EPSN pays a bit more dividend than its industry peers.
EPSN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.32.
Industry RankSector Rank
Dividend Yield 5.25%

5.2 History

EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

93.55% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (12/3/2025, 8:22:28 PM)

After market: 5.04 0 (0%)

5.04

+0.36 (+7.69%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-17 2026-03-17
Inst Owners75.39%
Inst Owner Change-3.95%
Ins Owners4.75%
Ins Owner Change0.82%
Market Cap122.47M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (70.04%)
Short Float %2.03%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 5.25%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-Date09-15 2025-09-15 (0.0625)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.29
Fwd PE 10.29
P/S 2.68
P/FCF 12.33
P/OCF 4.73
P/B 1.22
P/tB 1.22
EV/EBITDA 4.28
EPS(TTM)0.49
EY9.72%
EPS(NY)0.49
Fwd EY9.71%
FCF(TTM)0.41
FCFY8.11%
OCF(TTM)1.07
OCFY21.15%
SpS1.88
BVpS4.12
TBVpS4.12
PEG (NY)0.05
PEG (5Y)N/A
Graham Number6.74
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 3.18
F-Score7
WACC8.73%
ROIC/WACC0.81
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a valuation rating of 8 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Undervalued.


Can you provide the profitability details for EPSILON ENERGY LTD?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 6 / 10.


What are the PE and PB ratios of EPSILON ENERGY LTD (EPSN) stock?

The Price/Earnings (PE) ratio for EPSILON ENERGY LTD (EPSN) is 10.29 and the Price/Book (PB) ratio is 1.22.


What is the financial health of EPSILON ENERGY LTD (EPSN) stock?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 8 / 10.